SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: MECHANISMS OF DEVELOPMENT AND TARGETS FOR GENETIC ENGINEERING BIOLOGICAL THERAPY

SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: MECHANISMS OF DEVELOPMENT AND TARGETS FOR GENETIC ENGINEERING BIOLOGICAL THERAPY

.

Saved in:

Bibliographic Details
Main Author:	Alexei A. Grom
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2012-05-01
Series:	Вопросы современной педиатрии
Online Access:	https://vsp.spr-journal.ru/jour/article/view/501
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis
by: Kim Nguyen, et al.
Published: (2025-07-01)

Gene engineering biological therapy for juvenile arthritis
by: Kh Mikhel's, et al.
Published: (2011-02-01)

Using genetics, genomics, and transcriptomics to identify therapeutic targets in juvenile idiopathic arthritis
by: Evan Tarbell, et al.
Published: (2025-04-01)

Choice and switch of biologic drugs in juvenile idiopathic arthritis
by: Seher Şener, et al.
Published: (2023-12-01)

Treatment of systemic juvenile idiopathic arthritis: conventional treatment versus biologics
by: Seher Şener, et al.
Published: (2025-02-01)

Methotrexate in the combination therapy of juvenile idiopathic arthritis
by: E. S. Zholobova, et al.
Published: (2018-09-01)

Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review
by: Ekaterina I. Alekseeva, et al.
Published: (2019-06-01)

PHARMACOECONOMIC ISSUES OF ADALIMUMAB THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS
by: K. Simpson, et al.
Published: (2012-08-01)

CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

Biological therapy of seropositive juvenile idiopathic arthritis: Results of a retrospective single-center study
by: M. I. Kaleda, et al.
Published: (2023-06-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

EFFICACY AND SAFETY OF ANTI-TNFα HUMAN MONOCLONAL ANTIBODIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND SECONDARY RESISTANCE TO OTHER GENETICALLY ENGINEERED BIOLOGICAL AGENTS
by: E. I. Alexeeva, et al.
Published: (2012-07-01)

Juvenile idiopathic arthritis: clinical case
by: I. V. Zorin, et al.
Published: (2023-08-01)

Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
by: Maša Bizjak, et al.
Published: (2025-08-01)

THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: M. I. Kaleda, et al.
Published: (2018-01-01)

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis
by: Daniel Clemente, et al.
Published: (2025-04-01)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2020-08-01)

Effect of biologic treatments on growth in children with juvenile idiopathic arthritis: A systematic review.
by: Yasmine Makhlouf, et al.
Published: (2025-01-01)

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alekseeva, et al.
Published: (2017-04-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

Differences of hip involvement in systemic and non-systemic juvenile idiopathic arthritis
by: L. S. Sorokina, et al.
Published: (2022-03-01)

Assessment and Management of Pain in Juvenile Idiopathic Arthritis
by: Jennifer N Stinson, et al.
Published: (2012-01-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

TH-17 PHENOTYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: I. Z. Turtsevich1, et al.
Published: (2015-08-01)

Analysis of the Juvenile Idiopathic Arthritis Immunization Schedule
by: L. S. Namazova-Baranova, et al.
Published: (2016-11-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

Cardiopulmonary interactions in patients with juvenile idiopathic arthritis
by: L.F. Bogmat, et al.
Published: (2024-12-01)

Secondary Osteoporosis in Patients with Juvenile Idiopathic Arthritis
by: Kristyna Brabnikova Maresova
Published: (2011-01-01)

Cardiorenal interactions in patients with juvenile idiopathic arthritis
by: L. F. Bohmat, et al.
Published: (2024-01-01)

Spontaneous hyphema in juvenile idiopathic arthritis uveitis
by: Figen Bezci Aygun, et al.
Published: (2023-02-01)

Familial hypercholesterolemia mimicking juvenile idiopathic arthritis
by: Pooja Dhaon, et al.
Published: (2022-01-01)

Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
by: Irina Mikhailovna Marusenko
Published: (2013-12-01)

Juvenile Idiopathic Arthritis Associated Uveitis. Modern Therapy Approaches: Narrative Review
by: Alexandr A. Yakovlev, et al.
Published: (2025-07-01)

Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis
by: Lelia A. Galstian, et al.
Published: (2016-08-01)

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019-10-01)

Efficacy of rehabilitation therapy on hospital stage of treatment of patients with juvenile idiopathic arthritis
by: T A Shelepina, et al.
Published: (2008-06-01)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-09-01)

Subclinical Cardiovascular System Changes in Obese Patients with Juvenile Idiopathic Arthritis
by: Barbara Głowińska-Olszewska, et al.
Published: (2013-01-01)